We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Shockwaves Work Better Than Surgery for Removing Small Stones in the Ureter

By HospiMedica International staff writers
Posted on 02 Dec 2010
A new study states that extracorporeal shockwave lithotripsy (ESWL) should be the treatment of first choice in patients with a ureteric stone of up to one centimeter.

Researchers at the University Federico II (Naples, Italy) conducted a prospective randomized study involving 273 patients with single distal ureteric stones ranging from 0.5 cm - 1.5 cm, and compared the use of ESWL (137 patients) using an electromagnetic lithotripter to uretoscopy (URS, 136 patients), where an ureteroscope is passed into the distal ureter to remove the stone. More...
Patients in both groups were compared for overall stone-free rates (SFRs), re-treatment rates, need for auxiliary procedures, and complication rates. A subgroup analysis was performed in both groups according to stone size.

The results showed that the patients in the ESWL group achieved a 92.7% overall SFR, with a 44.88% re-treatment rate and an 11.02% auxiliary procedure rate; complications occurred in 15.32% of patients treated with ESWL. Patients in the URS group achieved a 94.85% overall SFR, with a re-treatment rate of 7.75% and an auxiliary procedure rate of 18.60%; complications occurred in 19.11% of patients treated with URS. The need for re-treatments and for auxiliary procedures, as well as the incidence of complications was significantly higher in patients with stones larger than one centimeter in the ESWL group. In patients with stones smaller than one centimeter treated with ESWL, the need for re-treatments and auxiliary procedures, as well as the incidence of complications, was significantly lower than for those treated with URS. The study was published in the December 2010 issue of the British Journal of Urology International (BJUI).

"Statistical analysis showed no significant differences in overall stone free rates, treatment duration, complications, and the need for auxiliary procedures,” said coauthor Professor Vincenzo Mirone, M.D., of the department of urology. "However, there were clear differences in both groups when we divided them into patients with stones of up to one centimeter and stones of over one centimeter.”

"Approximately one in three adults with kidney stones will have a distal ureteric stone at some point in their lives. Most stones with a diameter of up to 0.5 centimeter will be expelled spontaneously when the patient urinates without requiring any active intervention. For larger stones that get stuck in the ureter, spontaneous expulsion is very difficult and requires active intervention,” added Professor Mirone.

Related Links:

University Federico II





Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.